Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 303987, 9 pages
http://dx.doi.org/10.1155/2015/303987
Review Article

Potential Role of MicroRNA-210 as Biomarker in Human Cancers Detection: A Meta-Analysis

Department of Special Treatment, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, No. 225, Changhai Road, Shanghai 200438, China

Received 23 August 2014; Accepted 13 November 2014

Academic Editor: Aurelio Ariza

Copyright © 2015 Jiongjiong Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, E. Ward et al., “Cancer statistics, 2008,” CA: A Cancer Journal for Clinicians, vol. 58, no. 2, pp. 71–96, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. X. Li, K. Wu, and D. Fan, “CIAPIN1 as a therapeutic target in cancer,” Expert Opinion on Therapeutic Targets, vol. 14, no. 6, pp. 603–610, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. R. J. Motzer, M. Mazumdar, J. Bacik, W. Berg, A. Amsterdam, and J. Ferrara, “Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma,” Journal of Clinical Oncology, vol. 17, no. 8, pp. 2530–2540, 1999. View at Google Scholar · View at Scopus
  5. H. Iwamoto, Y. Kanda, T. Sejima, M. Osaki, F. Okada, and A. Takenaka, “Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma,” International Journal of Oncology, vol. 44, no. 1, pp. 53–58, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. J. K. Frost, W. C. Ball Jr., M. L. Levin et al., “Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins Study,” American Review of Respiratory Disease, vol. 130, no. 4, pp. 549–554, 1984. View at Google Scholar · View at Scopus
  7. F. R. Hirsch, W. A. Franklin, A. F. Gazdar, and Jr. Bunn P. A., “Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology,” Clinical Cancer Research, vol. 7, no. 1, pp. 5–22, 2001. View at Google Scholar · View at Scopus
  8. J. Wittmann and H.-M. Jäck, “Serum microRNAs as powerful cancer biomarkers,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1806, no. 2, pp. 200–207, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Lumachi, A. A. Brandes, M. Ermani, G. Bruno, and P. Boccagni, “Sensitivity of serum tumor markers CEA and CA 15–3 in breast cancer recurrences and correlation with different prognostic factors,” Anticancer Research, vol. 20, no. 6C, pp. 4751–4755, 2000. View at Google Scholar · View at Scopus
  10. J. Schneider, H.-G. Velcovsky, H. Morr, N. Katz, K. Neu, and E. Eigenbrodt, “Comparison of the tumor markers Tumor M2-PK, CEA, CYFRA 21-1, NSE and SCC in the diagnosis of lung cancer,” Anticancer Research, vol. 20, no. 6 D, pp. 5053–5058, 2000. View at Google Scholar · View at Scopus
  11. H. A. Dbouk, A. Tawil, F. Nasr et al., “Significance of CEA and VEGF as diagnostic markers of colorectal cancer in Lebanese patients,” The Open Clinical Cancer Journal, vol. 1, pp. 1–5, 2007. View at Google Scholar
  12. S. M. Hanash, C. S. Baik, and O. Kallioniemi, “Emerging molecular biomarkers-blood-based strategies to detect and monitor cancer,” Nature Reviews Clinical Oncology, vol. 8, no. 3, pp. 142–150, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Hutvágner and P. D. Zamore, “A microRNA in a multiple-turnover RNAi enzyme complex,” Science, vol. 297, no. 5589, pp. 2056–2060, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Esquela-Kerscher and F. J. Slack, “Oncomirs—microRNAs with a role in cancer,” Nature Reviews Cancer, vol. 6, no. 4, pp. 259–269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Zhang, X. Pan, G. P. Cobb, and T. A. Anderson, “microRNAs as oncogenes and tumor suppressors,” Developmental Biology, vol. 302, no. 1, pp. 1–12, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Wang, J. Chen, P. Chang et al., “MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease,” Cancer Prevention Research, vol. 2, no. 9, pp. 807–813, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Xing, N. W. Todd, L. Yu, H. Fang, and F. Jiang, “Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers,” Modern Pathology, vol. 23, no. 8, pp. 1157–1164, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Shen, Z. Liu, N. W. Todd et al., “Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers,” BMC Cancer, vol. 11, article 374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. P. S. Mitchell, R. K. Parkin, E. M. Kroh et al., “Circulating microRNAs as stable blood-based markers for cancer detection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513–10518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. J. A. Weber, D. H. Baxter, S. Zhang et al., “The microRNA spectrum in 12 body fluids,” Clinical Chemistry, vol. 56, no. 11, pp. 1733–1741, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Chen, Y. Ba, L. Ma et al., “Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases,” Cell Research, vol. 18, no. 10, pp. 997–1006, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Turchinovich, L. Weiz, A. Langheinz, and B. Burwinkel, “Characterization of extracellular circulating microRNA,” Nucleic Acids Research, vol. 39, no. 16, pp. 7223–7233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Kulshreshtha, M. Ferracin, S. E. Wojcik et al., “A microRNA signature of hypoxia,” Molecular and Cellular Biology, vol. 27, no. 5, pp. 1859–1867, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Osman, “MicroRNAs in health and disease—basic science and clinical applications,” Clinical Laboratory, vol. 58, no. 5-6, pp. 393–402, 2012. View at Google Scholar · View at Scopus
  25. M. E. Crosby, C. M. Devlin, P. M. Glazer, G. A. Calin, and M. Ivan, “Emerging roles of microRNAs in the molecular responses to hypoxia,” Current Pharmaceutical Design, vol. 15, no. 33, pp. 3861–3866, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Shen, N. W. Todd, H. Zhang et al., “Plasma microRNAs as potential biomarkers for non-small-cell lung cancer,” Laboratory Investigation, vol. 91, no. 4, pp. 579–587, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Xie, Z. Chu, and H. Wang, “Serum microRNA expression profile as a biomarker in diagnosis and prognosis of acute myeloid leukemia,” Journal of Clinical Pediatric Dentistry, vol. 30, no. 5, pp. 421–424, 2012. View at Google Scholar
  28. N. Anjuman, N. Li, M. Guarnera, S. A. Stass, and F. Jiang, “Evaluation of lung flute in sputum samples for molecular analysis of lung cancer,” Clinical and Translational Medicine, vol. 2, article 15, 2013. View at Publisher · View at Google Scholar
  29. D. Madhavan, K. Cuk, B. Burwinkel, and R. Yang, “Cancer diagnosis and prognosis decoded by blood-based circulating micro RNA signatures,” Frontiers in Genetics, vol. 4, article 116, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Hong, J. Yang, Y. Han, Q. Lu, J. Cao, and L. Syed, “High expression of miR-210 predicts poor survival in patients with breast cancer: a meta-analysis,” Gene, vol. 507, no. 2, pp. 135–138, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Li, X. Ma, J. Zhao, B. Zhang, Z. Jing, and L. Liu, “microRNA-210 as a prognostic factor in patients with breast cancer: meta-analysis,” Cancer Biomarkers, vol. 13, no. 6, pp. 471–481, 2013. View at Google Scholar
  32. D. Madhavan, M. Zucknick, M. Wallwiener et al., “Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer,” Clinical Cancer Research, vol. 18, no. 21, pp. 5972–5982, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Ren, J. Gao, J.-Q. Liu et al., “Differential signature of fecal microRNAs in patients with pancreatic cancer,” Molecular Medicine Reports, vol. 6, no. 1, pp. 201–209, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Zhao, G. Li, M. Péoc'h, C. Genin, and M. Gigante, “Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma,” Experimental and Molecular Pathology, vol. 94, no. 1, pp. 115–120, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Li, J. Ma, M. A. Guarnera, H. Fang, L. Cai, and F. Jiang, “Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer,” Journal of Cancer Research and Clinical Oncology, vol. 140, no. 1, pp. 145–150, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Shen, J. Liao, M. A. Guarnera et al., “Analysis of microRNAs in sputum to improve computed tomography for lung cancer diagnosis,” Journal of Thoracic Oncology, vol. 9, no. 1, pp. 33–40, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. E. C. Vamvakas, “Meta-analyses of studies of the diagnostic accuracy of laboratory tests: a review of the concepts and methods,” Archives of Pathology & Laboratory Medicine, vol. 122, no. 8, pp. 675–686, 1998. View at Google Scholar · View at Scopus
  38. A. J. Mitchell, A. Vaze, and S. Rao, “Clinical diagnosis of depression in primary care: a meta-analysis,” The Lancet, vol. 374, no. 9690, pp. 609–619, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Dinnes, J. Deeks, J. Kirby, and P. Roderick, “A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy,” Health Technology Assessment, vol. 9, no. 12, pp. 1–113, 2005. View at Google Scholar · View at Scopus
  40. J. J. Deeks, P. Macaskill, and L. Irwig, “The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed,” Journal of Clinical Epidemiology, vol. 58, no. 9, pp. 882–893, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Devlin, S. Greco, F. Martelli, and M. Ivan, “MiR-210: more than a silent player in hypoxia,” IUBMB Life, vol. 63, no. 2, pp. 94–100, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. R. H. Wenger and M. Gassmann, “Oxygen(es) and the hypoxia-inducible factor-1,” Biological Chemistry, vol. 378, no. 7, pp. 609–616, 1997. View at Google Scholar · View at Scopus
  43. C. S. Neal, M. Z. Michael, L. H. Rawlings, M. B. van der Hoek, and J. M. Gleadle, “The VHL-dependent regulation of microRNAs in renal cancer,” BMC Medicine, vol. 8, article 64, 2010. View at Publisher · View at Google Scholar · View at Scopus